Research output per year
Research output per year
Fingerprint
Dive into the research topics where Dirk Van Den Berge is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
-
Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? A case report and review of the literature
Kamel, R. & Van Den Berge, D., Dec 2024, In: J Med Case Rep. 18, 1, 8 p., 330.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series
Tijtgat, J., Calliauw, E., Dirven, I., Vounckx, M., Kamel, R., Vanbinst, A. M., Everaert, H., Seynaeve, L., Berge, D. V. D., Duerinck, J. & Neyns, B., May 2023, In: Cancers (Basel). 15, 9, 13 p., 2560.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Citations (Scopus)63 Downloads (Pure) -
18F-FDG PET/CT Findings in Neurofibromatosis Type 3
Jonckheere, J., Everaert, H., Van Den Berge, D., Goethals, L., Döring, S. & De Mey, J., 2020, In: International Journal of Clinical and Medical Imaging. 7, 3, p. 679-679 1 p.Research output: Contribution to journal › Article › peer-review
-
P04.03 Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? Case report and review of the literature
Kamel, R. & Van Den Berge, D., Sep 2019, In: Neuro-Oncology. 21, 3, p. 29 1 p.Research output: Contribution to journal › Meeting abstract (Journal)
-
Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species
Wang, H., Bouzakoura, S., de Mey, S., Jiang, H., Law, K., Dufait, I., Corbet, C., Verovski, V., Gevaert, T., Feron, O., Van den Berge, D., Storme, G. & De Ridder, M., May 2017, In: Oncotarget. 8, 22, p. 35728-35742 15 p.Research output: Contribution to journal › Article › peer-review
Open Access71 Citations (Scopus)
Activities
- 1 Talk or presentation at a conference
-
Strategieën bij de behandeling van glioomen
Sven Gläsker (Speaker) & Dirk Van Den Berge (Speaker)
21 Feb 2018Activity: Talk or presentation › Talk or presentation at a conference